Rebecca Cohen

Investor Relations Kontakt bei IKENA ONCOLOGY, INC.

Health Technology

Consumer Services

Aktive Positionen von Rebecca Cohen

Unternehmen	Position	Beginn	Ende
IKENA ONCOLOGY, INC.	Investor Relations Kontakt	-	-

Unternehmen	Position	Beginn	Ende
SQZ BIOTECHNOLOGIES COMPANY	Investor Relations Kontakt	01.01.2017	01.07.2018
SQZ BIOTECHNOLOGIES COMPANY	Public Communications Contact	01.01.2017	01.07.2018
EPIZYME, INC.	Public Communications Contact	-	01.05.2016
Jewish Big Brothers Big Sisters of Greater Boston	Direktor/Vorstandsmitglied	-	-
Solomon Schechter Day School of Greater Boston	Direktor/Vorstandsmitglied	-	-
MESOBLAST LIMITED	Technik-/Wissenschafts-/F&E-Leiter	-	-

Rutgers State University of New Jersey

Undergraduate Degree

International

Vereinigte Staaten	7
Australien	2

Operativ

Public Communications Contact	2
Investor Relations Contact	2
Director/Board Member	2

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
SQZ BIOTECHNOLOGIES COMPANY	Health Technology
IKENA ONCOLOGY, INC.	Health Technology
MESOBLAST LIMITED	Health Technology

Private Unternehmen	3
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology
Solomon Schechter Day School of Greater Boston
Jewish Big Brothers Big Sisters of Greater Boston